跳至主要内容
临床试验/NL-OMON33687
NL-OMON33687尚未招募4 期

Glucose lowering by continuous tube feeding and Vildagliptin in addition to insulin in hyperglycemic acute stroke patients. - GLUCOVAS

Academisch Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) Supra-tentorial stroke with a time of onset within 24h before presentation.
  • 2) An acute neurological deficit measurable with the National Institute of Health Stroke Score (NIHSS, see appendix I) >= 4 at presentation.
  • 3) Venous plasma admission glucose > 7.0 mmol/l
  • 4) Informed consent.

排除标准

  • 1) Signs of cerebral hemorrhage on computed tomography scan
  • 2) Previous history of diabetes mellitus treated with insulin
  • 3) Patients in whom death appears imminent
  • 4) Renal insufficiency defined as creatinine > 150 mmol/L
  • 5) Patients under the age of 18
  • 6) Pregnant patients
  • 7) Expected transfer to a different hospital within 5 days.

研究者

相似试验